AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."

① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.

cls.cnApr 11 07:59 ET

Shuttle Pharmaceuticals Announces Filing Of Key Provisional Patent Application With The United States Patent And Trademark Office Entitled "PSMA-Targeted PARP Inhibitor Conjugates for Precision Cancer Therapy"

BenzingaApr 10 16:03 ET

Express News | Shuttle Pharmaceuticals Holdings Inc - on March 21, Enters Consulting Agreement With Bowery Consulting - SEC Filing

ReutersMar 25 16:21 ET

The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.

Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.

Zhitong FinanceMar 18 03:00 ET

New York Manufacturing Hits Low, Inflation Fears Rise

InvestingMar 17 08:50 ET

Cellectis CLLS Earnings; Shuttle Pharmaceuticals SHPH Offering

BioPharmCatalystMar 14 08:50 ET

12 Health Care Stocks Moving In Wednesday's Intraday Session

BenzingaMar 12 13:07 ET

Shuttle Pharmaceuticals Prices 19.17M Shares at 30c per Share in Public Offering

TipRanksMar 12 09:30 ET

Express News | Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering

ReutersMar 12 09:24 ET

Press Release: Shuttle Pharma Announces Pricing of $5.75 Million Underwritten Offering

Dow JonesMar 12 09:24 ET

Shuttle Pharmaceuticals: Chairman Anatoly Dritschilo to Continue as Co-CEO Overseeing Scientific and Clinical Trial Activities >SHPH

Dow JonesMar 12 06:21 ET

Press Release: Shuttle Pharma Announces Appointment of Christopher Cooper as Interim Co-CEO to Enhance Business Activities

Dow JonesMar 12 06:20 ET

Express News | Shuttle Pharma Announces Appointment of Christopher Cooper as Interim Co-CEO to Enhance Business Activities

ReutersMar 12 06:20 ET

Express News | Shuttle Pharmaceuticals Holdings Inc - Offering up to 10,000,000 Shares of Common Stock

ReutersMar 5 06:50 ET

Shuttle Pharmaceuticals Enters Revolving Loan Agreement

TipRanksFeb 28 17:50 ET

Express News | Shuttle Pharmaceuticals Holdings Inc - Enters $2 Million Revolving Loan Agreement

ReutersFeb 28 17:25 ET

Shuttle Pharmaceuticals Provides Corporate Update On Phase 2 Glioblastoma Trial Enrollment, Diagnostics Advancements With UCSF, Launch Of New Corporate Website, And $237,500 Investment By CEO Dr. Anatoly Dritschilo And Other Investors In Recent Financing

BenzingaFeb 26 10:49 ET

Express News | Shuttle Pharmaceuticals FY24 EPS $(3.30) Vs $(3.53) YoY

BenzingaFeb 26 10:48 ET

Shuttle Pharma Provides Corporate Update and Reports 2024 Results

GlobeNewswireFeb 26 10:45 ET

Shuttle Pharmaceuticals | 10-K: FY2024 Annual Report

SECFeb 26 10:22 ET · Announcements